STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. IV. CLINICAL APPLICATION OF A QUANTITATIVE ANTIFIBRINOLYSIN TEST

^{Respiratory Diseases Commission Laboratory, Regional Station Hospital, Section 2, Fort Bragg, North Carolina}

Members and professional associates of the Commission on Acute Respiratory Diseases are John H. Dingle, Major, M.C., A.U.S., Director; Theodore J. Abernethy, Major, M.C., A.U.S.; George F. Badger, Major, M.C., A.U.S.; Norman L. Cressy, Major, M.C., A.U.S.; A. E. Feller, M.D.; Irving Gordon, M.D.; Alexander D. Langmuir, Major, M.C., A.U.S.; Charles H. Rammelkamp, M.D.; Elias Strauss, Captain, M.C., A.U.S., and Hugh Tatlock, Captain, M.C., A.U.S.

This investigation was supported through the Commission on Acute Respiratory Diseases, Board for the Investigation and Control of Influenza and Other Epidemic Diseases in the Army, Preventive Medicine Service, Office of The Surgeon General, United States Army, and by grants from the Commonwealth Fund, the W. K. Kellogg Foundation, the John and Mary R. Markle Foundation and the International Health Division of the Rockefeller Foundation to the Board for the Investigation and Control of Influenza and Other Epidemic Diseases for the Commission on Acute Respiratory Diseases.